These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 22956368)
1. Loss of microRNA-200a and c, and microRNA-203 expression at the invasive front of primary cutaneous melanoma is associated with increased thickness and disease progression. van Kempen LC; van den Hurk K; Lazar V; Michiels S; Winnepenninckx V; Stas M; Spatz A; van den Oord JJ Virchows Arch; 2012 Oct; 461(4):441-8. PubMed ID: 22956368 [TBL] [Abstract][Full Text] [Related]
2. miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1. Liu S; Tetzlaff MT; Cui R; Xu X Am J Pathol; 2012 Nov; 181(5):1823-35. PubMed ID: 22982443 [TBL] [Abstract][Full Text] [Related]
3. Loss of microRNA-205 expression is associated with melanoma progression. Liu S; Tetzlaff MT; Liu A; Liegl-Atzwanger B; Guo J; Xu X Lab Invest; 2012 Jul; 92(7):1084-96. PubMed ID: 22525428 [TBL] [Abstract][Full Text] [Related]
4. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. Bachmann IM; Straume O; Puntervoll HE; Kalvenes MB; Akslen LA Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8606-14. PubMed ID: 16361544 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of intratumoral expression of miR-205, miR-200c and miR-125b in primary human cutaneous melanomas predicts shorter survival. Sánchez-Sendra B; Martinez-Ciarpaglini C; González-Muñoz JF; Murgui A; Terrádez L; Monteagudo C Sci Rep; 2018 Nov; 8(1):17076. PubMed ID: 30459436 [TBL] [Abstract][Full Text] [Related]
6. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389 [TBL] [Abstract][Full Text] [Related]
7. miR-128 targets the CC chemokine ligand 18 gene (CCL18) in cutaneous malignant melanoma progression. Song H; Tao Y; Ni N; Zhou X; Xiong J; Zeng X; Xu X; Qi J; Sun J J Dermatol Sci; 2018 Sep; 91(3):317-324. PubMed ID: 30025750 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-9 up-regulates E-cadherin through inhibition of NF-κB1-Snail1 pathway in melanoma. Liu S; Kumar SM; Lu H; Liu A; Yang R; Pushparajan A; Guo W; Xu X J Pathol; 2012 Jan; 226(1):61-72. PubMed ID: 22131135 [TBL] [Abstract][Full Text] [Related]
9. Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors. Xu Y; Brenn T; Brown ER; Doherty V; Melton DW Br J Cancer; 2012 Jan; 106(3):553-61. PubMed ID: 22223089 [TBL] [Abstract][Full Text] [Related]
11. Targeting GOLM1 by microRNA-200a in melanoma suppresses cell proliferation, invasion and migration via regulating PI3K/Akt signaling pathway and epithelial-mesenchymal transition. Chen WY; Xu YY; Zhang XY Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6997-7007. PubMed ID: 31486500 [TBL] [Abstract][Full Text] [Related]
12. In situ measurement of miR-205 in malignant melanoma tissue supports its role as a tumor suppressor microRNA. Hanna JA; Hahn L; Agarwal S; Rimm DL Lab Invest; 2012 Oct; 92(10):1390-7. PubMed ID: 22890556 [TBL] [Abstract][Full Text] [Related]
13. Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma. Kitago M; Martinez SR; Nakamura T; Sim MS; Hoon DS Clin Cancer Res; 2009 May; 15(9):2988-94. PubMed ID: 19336521 [TBL] [Abstract][Full Text] [Related]
14. microRNA-10b is a prognostic biomarker for melanoma. Saldanha G; Elshaw S; Sachs P; Alharbi H; Shah P; Jothi A; Pringle JH Mod Pathol; 2016 Feb; 29(2):112-21. PubMed ID: 26743475 [TBL] [Abstract][Full Text] [Related]
15. Expression of miR-203 is decreased and associated with the prognosis of melanoma patients. Wang K; Zhang ZW Int J Clin Exp Pathol; 2015; 8(10):13249-54. PubMed ID: 26722525 [TBL] [Abstract][Full Text] [Related]
16. MiRNAs as Potential Prognostic Biomarkers for Metastasis in Thin and Thick Primary Cutaneous Melanomas. Valentini V; Zelli V; Gaggiano E; Silvestri V; Rizzolo P; Bucalo A; Calvieri S; Grassi S; Frascione P; Donati P; Soda G; Ottini L; Richetta AG Anticancer Res; 2019 Aug; 39(8):4085-4093. PubMed ID: 31366492 [TBL] [Abstract][Full Text] [Related]
17. The Expression of miR-211-5p in Sentinel Lymph Node Metastases of Malignant Melanoma Is a Potential Marker for Poor Prognosis. Moritz RKC; Ebelt N; Rattay T; Ehrenreich J; Sunderkötter C; Gerloff D Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409187 [TBL] [Abstract][Full Text] [Related]
18. Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression. Krengel S; Grotelüschen F; Bartsch S; Tronnier M J Cutan Pathol; 2004 Jan; 31(1):1-7. PubMed ID: 14675278 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-329 upregulation impairs the HMGB2/β-catenin pathway and regulates cell biological behaviors in melanoma. Mo Y; Fang RH; Wu J; Si Y; Jia SQ; Li Q; Bai JZ; She XN; Wang JQ J Cell Physiol; 2019 Dec; 234(12):23518-23527. PubMed ID: 31219186 [TBL] [Abstract][Full Text] [Related]
20. E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis. Silvestri S; Porcellato I; Mechelli L; Menchetti L; Iussich S; De Maria R; Sforna M; Bongiovanni L; Brachelente C Vet Pathol; 2020 Sep; 57(5):608-619. PubMed ID: 32578507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]